CVE-2025-2230

Philips Intellispace Cardiovascular (ISCV) Improper Authentication

CVSS 8.5 HIGHEPSS 0.2%CWE-287

Vexday Risk Score

21Low

SSVC decision (CISA)

Track

No exploitation signal → monitor

CVSS 8.5EPSS 0.2%KEV nãoPoC —Nuclei —Metasploit —Patch —

Lifecycle

13 Mar 2025Published on NVD

Recommendation: Monitor — no exploitation signal at the moment.

A flaw exists in the Windows login flow where an AuthContext token can be exploited for replay attacks and authentication bypass.

CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N

Affected products

Want to know if your infrastructure is exposed to this?

References